Phl p 1-specific human monoclonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment

Journal of Immunology

Volumn 191, Issue 2, 2013, Pages 551-560

  Levin, Mattias ^a   Rydnert, Frida ^a   Källström, Eva ^b   Tan, Lor Wai ^c   Wormald, Peter J ^c   Lindstedt, Malin ^a   Greiff, Lennart ^b   Ohlin, Mats ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY; MAJOR TIMOTHY GROUP 1 POLLEN ALLERGEN PHL P 1; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ALLERGENICITY; ALLERGIC REACTION; ANTIBODY PRODUCTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CROSS REACTION; DEGRANULATION; DRUG DESIGN; EPITOPE MAPPING; GENETIC ANALYSIS; GRASS POLLEN; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING;

ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, PLANT; BINDING SITES, ANTIBODY; CROSS REACTIONS; EPITOPES; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MICE; MOLECULAR SEQUENCE DATA; PLANT EXTRACTS; PLANT PROTEINS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEQUENCE ALIGNMENT;

EID: 84880104666     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202051     Document Type: Article

References (54)

1. Finkelman, F. D., and D. Vercelli. 2007. Advances in asthma, allergy mechanisms, and genetics in 2006. J. Allergy Clin. Immunol. 120: 544-550. (Pubitemid 47320758)
2. Gould, H. J., B. J. Sutton, A. J. Beavil, R. L. Beavil, N. McCloskey, H. A. Coker, D. Fear, and L. Smurthwaite. 2003. The biology of IGE and the basis of allergic disease. Annu. Rev. Immunol. 21: 579-628. (Pubitemid 37174542)
3. Gould, H. J., and B. J. Sutton. 2008. IgE in allergy and asthma today. Nat. Rev. Immunol. 8: 205-217. (Pubitemid 351323292)
4. Andersson, K., and J. Lidholm. 2003. Characteristics and immunobiology of grass pollen allergens. Int. Arch. Allergy Immunol. 130: 87-107. (Pubitemid 36351233)
5. Kiotseridis, H., C. M. Cilio, L. Bjermer, M. Aurivillius, H. Jacobsson, and A. Tunsäter. 2011. Swedish translation and validation of the Pediatric Allergic Disease Quality of Life Questionnaire (PADQLQ). Acta Paediatr. 100: 242-247.
6. Hellgren, J., A. Cervin, S. Nordling, A. Bergman, and L. O. Cardell. 2010. Allergic rhinitis and the common cold: high cost to society. Allergy 65: 776-783.
7. Durham, S. R., S. M. Walker, E. M. Varga, M. R. Jacobson, F. O'Brien, W. Noble, S. J. Till, Q. A. Hamid, and K. T. Nouri-Aria. 1999. Long-term clinical efficacy of grass-pollen immunotherapy. N. Engl. J. Med. 341: 468-475. (Pubitemid 29372886)
8. Noon, L. 1911. Prophylactic inoculation against hay fever. Lancet 177: 1572-1573.
9. Focke, M., I. Swoboda, K. Marth, and R. Valenta. 2010. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clin. Exp. Allergy 40: 385-397.
10. Mellerup, M. T., G. W. Hahn, L. K. Poulsen, and H. Malling. 2000. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin. Exp. Allergy 30: 1423-1429.
11. Valenta, R., K. Niespodziana, M. Focke-Tejkl, K. Marth, H. Huber, A. Neubauer, and V. Niederberger. 2011. Recombinant allergens: what does the future hold? J. Allergy Clin. Immunol. 127: 860-864.
12. Valenta, R., T. Ball, M. Focke, B. Linhart, N. Mothes, V. Niederberger, S. Spitzauer, I. Swoboda, S. Vrtala, K. Westritschnig, and D. Kraft. 2004. Immunotherapy of allergic disease. Adv. Immunol. 82: 105-153. (Pubitemid 38213117)
13. Wachholz, P. A., N. K. Soni, S. J. Till, and S. R. Durham. 2003. Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J. Allergy Clin. Immunol. 112: 915-922. (Pubitemid 37412059)
14. Mothes, N., M. Heinzkill, K. J. Drachenberg, W. R. Sperr, M. T. Krauth, Y. Majlesi, H. Semper, P. Valent, V. Niederberger, D. Kraft, and R. Valenta. 2003. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin. Exp. Allergy 33: 1198-1208. (Pubitemid 37108522)
15. Larché, M. 2006. Immunoregulation by targeting T cells in the treatment of allergy and asthma. Curr. Opin. Immunol. 18: 745-750. (Pubitemid 44635181)
16. Laffer, S., S. Vrtala, M. Duchêne, R. van Ree, D. Kraft, O. Scheiner, and R. Valenta. 1994. IgE-binding capacity of recombinant timothy grass (Phleum pratense) pollen allergens. J. Allergy Clin. Immunol. 94: 88-94. (Pubitemid 24219663)
17. Duffort, O., J. Quintana, H. Ipsen, D. Barber, and F. Polo. 2008. Antigenic similarity among group 1 allergens from grasses and quantitation ELISA using monoclonal antibodies to Phl p 1. Int. Arch. Allergy Immunol. 145: 283-290. (Pubitemid 351416709)
18. Flicker, S., P. Steinberger, T. Ball, M. T. Krauth, P. Verdino, P. Valent, S. Almo, and R. Valenta. 2006. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity. J. Allergy Clin. Immunol. 117: 1336-1343. (Pubitemid 43795725)
19. Laffer, S., M. Duchene, I. Reimitzer, M. Susani, C. Mannhalter, D. Kraft, and R. Valenta. 1996. Common IgE-epitopes of recombinant Phl p I, the major timothy grass pollen allergen and natural group I grass pollen isoallergens. Mol. Immunol. 33: 417-426. (Pubitemid 26191486)
20. Tamborini, E., S. Faccini, J. Lidholm, M. Svensson, A. Brandazza, R. Longhi, H. Groenlund, A. Sidoli, and P. Arosio. 1997. Biochemical and immunological characterization of recombinant allergen Lol p 1. Eur. J. Biochem. 249: 886-894. (Pubitemid 27479064)
21. Smith, P. M., A. Avjioglu, L. R. Ward, R. J. Simpson, R. B. Knox, and M. B. Singh. 1994. Isolation and characterization of group-I isoallergens from Bermuda grass pollen. Int. Arch. Allergy Immunol. 104: 57-64. (Pubitemid 24133314)
22. Andréasson, U., S. Flicker, M. Lindstedt, R. Valenta, L. Greiff, M. Korsgren, C. A. Borrebaeck, and M. Ohlin. 2006. The human IgE-encoding transcriptome to assess antibody repertoires and repertoire evolution. J. Mol. Biol. 362: 212-227. (Pubitemid 44278844)
23. Persson, H., S. Flicker, M. K. Sadegh, L. Greiff, R. Valenta, and M. Ohlin. 2008. A common idiotype in IgE and its relation to recognition of the grass pollen allergen Phl p 2. Mol. Immunol. 45: 2715-2720.
24. Persson, H., H. Wallmark, A. Ljungars, J. Hallborn, and M. Ohlin. 2008. In vitro evolution of an antibody fragment population to find high-affinity hapten binders. Protein Eng. Des. Sel. 21: 485-493. (Pubitemid 352019919)
25. Christensen, L. H., J. Holm, G. Lund, E. Riise, and K. Lund. 2008. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. J. Allergy Clin. Immunol. 122: 298-304.
26. Christensen, L. H., E. Riise, L. Bang, C. Zhang, and K. Lund. 2010. Isoallergen variations contribute to the overall complexity of effector cell degranulation: effect mediated through differentiated IgE affinity. J. Immunol. 184: 4966-4972.
27. Holm, J., N. Willumsen, P. A. Würtzen, L. H. Christensen, and K. Lund. 2011. Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity. J. Allergy Clin. Immunol. 127: 1029-1037.
28. Persson, H., M. K. Sadegh, L. Greiff, and M. Ohlin. 2007. Delineating the specificity of an IgE-encoding transcriptome. J. Allergy Clin. Immunol. 120: 1186-1192. (Pubitemid 350029890)
29. Levin, M., L. W. Tan, L. Baker, P. J. Wormald, L. Greiff, and M. Ohlin. 2011. Diversity of immunoglobulin E-encoding transcripts in sinus mucosa of subjects diagnosed with non-allergic fungal eosinophilic sinusitis. Clin. Exp. Allergy 41: 811-820.
30. Moutel, S., A. El Marjou, O. Vielemeyer, C. Nizak, P. Benaroch, S. Dübel, and F. A. Perez. 2009. A multi-Fc-species system for recombinant antibody production. BMC Biotechnol. 9: 14.
31. Brochet, X., M. P. Lefranc, and V. Giudicelli. 2008. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36(Web Server issue): W503-W508.
32. Lefranc, M. P. 1997. The IMGT unique numbering for Immunoglobulins, T cell receptors and Ig-like domains. The Immunologist 7: 132-136.
33. Boyd, S. D., B. A. Gaëta, K. J. Jackson, A. Z. Fire, E. L. Marshall, J. D. Merker, J. M. Maniar, L. N. Zhang, B. Sahaf, C. D. Jones, et al. 2010. Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. J. Immunol. 184: 6986-6992.
34. Xu, J. L., and M. M. Davis. 2000. Diversity in the CDR3 region of V H is sufficient for most antibody specificities. Immunity 13: 37-45.
35. Kerzel, S., T. Rogosch, B. Struecker, R. F. Maier, and M. Zemlin. 2010. IgE transcripts in the circulation of allergic children reflect a classical antigen-driven B cell response and not a superantigen-like activation. J. Immunol. 185: 2253-2260.
36. Mari, A., C. Rasi, P. Palazzo, and E. Scala. 2009. Allergen databases: current status and perspectives. Curr. Allergy Asthma Rep. 9: 376-383.
37. Flicker, S., P. Steinberger, L. Norderhaug, W. R. Sperr, Y. Majlesi, P. Valent, D. Kraft, and R. Valenta. 2002. Conversion of grass pollen allergen-specific human IgE into a protective IgG1 antibody. Eur. J. Immunol. 32: 2156-2162. (Pubitemid 34965878)
38. van Ree, R., and R. C. Aalberse. 1995. Rabbit IgG directed to a synthetic C-terminal peptide of the major grass pollen allergen Lol p I inhibits human basophil histamine release induced by natural Lol p I. Int. Arch. Allergy Immunol. 106: 250-257.
39. Ball, T., T. Fuchs, W. R. Sperr, P. Valent, L. Vangelista, D. Kraft, and R. Valenta. 1999. B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy. FASEB J. 13: 1277-1290. (Pubitemid 29382497)
40. Focke, M., V. Mahler, T. Ball, W. R. Sperr, Y. Majlesi, P. Valent, D. Kraft, and R. Valenta. 2001. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J. 15: 2042-2044.
41. Ball, T., B. Linhart, K. Sonneck, K. Blatt, H. Herrmann, P. Valent, A. Stoecklinger, C. Lupinek, J. Thalhamer, A. A. Fedorov, et al. 2009. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination. Allergy 64: 569-580.
42. Oseroff, C., J. Sidney, M. F. Kotturi, R. Kolla, R. Alam, D. H. Broide, S. I. Wasserman, D. Weiskopf, D. M. McKinney, J. L. Chung, et al. 2010. Molecular determinants of T cell epitope recognition to the common timothy grass allergen. J. Immunol. 185: 943-955.
43. Axelsson, F., S. P. Adler, A. Lamarre, and M. Ohlin. 2007. Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines. Vaccine 26: 41-46. (Pubitemid 350213210)
44. Ohlin, M., B. Plachter, V. A. Sundqvist, P. G. A. Steenbakkers, J. M. Middeldorp, and C. A. K. Borrebaeck. 1995. Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus. Clin. Diagn. Lab. Immunol. 2: 325-329.
45. Sutherland, J. N., C. Chang, S. M. Yoder, M. T. Rock, and J. A. Maynard. 2011. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization. Clin. Vaccine Immunol. 18: 954-962.
46. Trible, B. R., M. Kerrigan, N. Crossland, M. Potter, K. Faaberg, R. Hesse, and R. R. Rowland. 2011. Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease. Clin. Vaccine Immunol. 18: 749-757.
47. Cheng, C., J. G. Gall, M. Nason, C. R. King, R. A. Koup, M. Roederer, M. J. McElrath, C. A. Morgan, G. Churchyard, L. R. Baden, et al. 2010. Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization. J. Virol. 84: 630-638.
48. Sudowe, S., A. Rademaekers, and E. Kölsch. 1997. Antigen dose-dependent predominance of either direct or sequential switch in IgE antibody responses. Immunology 91: 464-472. (Pubitemid 27304284)
49. Van Milligen, F. J., S. Craig, B. L. Rogers, P. Van Swieten, and R. C. Aalberse. 1995. Differences between specificities of IgE and IgG4 antibodies: studies using recombinant chain 1 and chain 2 of the major cat allergen Felis domesticus (Fel d) I. Clin. Exp. Allergy 25: 247-251.
50. Steinberger, P., D. Kraft, and R. Valenta. 1996. Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5. J. Biol. Chem. 271: 10967-10972.
51. Gorny, M. K., J. Sampson, H. Li, X. Jiang, M. Totrov, X. H. Wang, C. Williams, T. O'Neal, B. Volsky, L. Li, et al. 2011. Human anti-V3 HIV-1 monoclonal antibodies encoded by the VH5-51/VL lambda genes define a conserved antigenic structure. PLoS ONE 6: e27780.
52. Lingwood, D., P. M. McTamney, H. M. Yassine, J. R. Whittle, X. Guo, J. C. Boyington, C. J.Wei, and G. J. Nabel. 2012. Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature 489: 566-570.
53. Chabre, H., B. Gouyon, A. Huet, V. Baron-Bodo, E. Nony, M. Hrabina, F. Fenaille, A. Lautrette, M. Bonvalet, B. Maillère, et al. 2010. Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapy. Clin. Exp. Allergy 40: 505-519.
54. Fenaille, F., E. Nony, H. Chabre, A. Lautrette, M. N. Couret, T. Batard, P. Moingeon, and E. Ezan. 2009. Mass spectrometric investigation of molecular variability of grass pollen group 1 allergens. J. Proteome Res. 8: 4014-4027.